SCHEMBL14824935

SCHEMBL14824935

INCCc1ccccn1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.67
HRH3 Q9Y5N1 1/20 0.66
ALDH1A1 P00352 2/20 0.63
LMNA P02545 2/20 0.63
TAAR1 Q96RJ0 1/20 0.63
ALOX15 P16050 1/20 0.63
CYP2C19 P33261 1/20 0.61
HRH1 P35367 2/20 0.55
TDP1 Q9NUW8 1/20 0.54
APP P05067 2/20 0.51
CYP2D6 P10635 1/20 0.50
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
CHRM2 P08172 2/20 0.47
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
DRD2 P14416 1/20 0.46
CHRM3 P20309 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1921574 0.83 HRH3 (0.70) CYP1A2HRH3ALDH1A1LMNATAAR1
SCHEMBL23053146 0.81 CYP1A2 (0.69) CYP1A2HRH3ALDH1A1LMNATAAR1
SCHEMBL27379291 0.80 CYP1A2 (0.62) CYP1A2HRH3ALDH1A1LMNATAAR1
SCHEMBL27513658 0.80 CYP1A2 (1.00) CYP1A2HRH3ALDH1A1LMNATAAR1
SCHEMBL14067280 0.80 CYP1A2 (0.62) CYP1A2HRH3ALDH1A1LMNATAAR1
SCHEMBL230753 0.79 HRH1 (0.73) CYP1A2HRH3ALDH1A1LMNATAAR1
SCHEMBL29485678 0.79 HRH1 (0.73) CYP1A2HRH3ALDH1A1LMNATAAR1
Betahistine SCHEMBL125582 0.79 HRH3 (1.00) CYP1A2HRH3ALDH1A1LMNATAAR1
SCHEMBL6890812 0.79 HRH3 (0.66) CYP1A2HRH3ALDH1A1LMNATAAR1
Betahistine SCHEMBL29354603 0.79 HRH3 (1.00) CYP1A2HRH3ALDH1A1LMNATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113629191-A Methylamine-pyridine mixed type perovskite solar cell with high stability 鲁东大学 2021-11-09 CN claimed
WO-2020113071-A1 COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER ARAXES PHARMA LLC (US) 2020-06-04 WO disclosed
EP-2024360-B1 SUBSTITUTED PYRAZOLOPYRIMIDINES CEPHALON INC (US) 2013-04-03 EP disclosed